J van Embden
About
J van Embden is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology.
According to data from OpenAlex, J van Embden has authored 24 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in J van Embden's work include Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (10 papers) and Heat shock proteins research (5 papers). J van Embden is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (10 papers) and Heat shock proteins research (5 papers). J van Embden collaborates with scholars based in Netherlands, United States and Guinea-Bissau. J van Embden's co-authors include Annelies Bunschoten, Leo M. Schouls, Dick van Soolingen, Sjoukje Kuijper, A H Kolk, Madhu Goyal, R J Shaw, H.O.F. Molhuizen, Stanley Falkow and Patricia Guerry and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.
In The Last Decade
J van Embden
24 papers receiving 3.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| J van Embden Netherlands | 21 | 3.0k | 3.0k | 1.7k | 894 | 340 | 24 | 4.1k | ||
| Angel Cataldi Argentina | 33 | 2.7k 0.9× | 2.5k 0.8× | 831 0.5× | 884 1.0× | 323 0.9× | 100 | 3.3k | ||
| Sofía Samper Spain | 30 | 3.3k 1.1× | 3.1k 1.0× | 1.6k 0.9× | 633 0.7× | 257 0.8× | 86 | 3.9k | ||
| Desmond M. Collins New Zealand | 39 | 2.6k 0.9× | 2.9k 1.0× | 546 0.3× | 1000 1.1× | 494 1.5× | 82 | 3.7k | ||
| Sjoukje Kuijper Netherlands | 25 | 3.3k 1.1× | 3.2k 1.1× | 1.9k 1.1× | 525 0.6× | 165 0.5× | 43 | 4.0k | ||
| J D van Embden Netherlands | 36 | 6.3k 2.1× | 6.0k 2.0× | 3.2k 1.9× | 1.2k 1.4× | 545 1.6× | 49 | 7.9k | ||
| Geoffrey W. de Lisle New Zealand | 46 | 3.7k 1.2× | 3.8k 1.3× | 633 0.4× | 1.0k 1.2× | 1.3k 3.8× | 109 | 5.2k | ||
| Janet Fyfe Australia | 34 | 1.4k 0.5× | 2.7k 0.9× | 474 0.3× | 1.0k 1.2× | 133 0.4× | 93 | 4.2k | ||
| Iñaki Comas Spain | 31 | 3.1k 1.0× | 2.8k 0.9× | 1.1k 0.6× | 1.5k 1.6× | 286 0.8× | 114 | 4.3k | ||
| Abu Salim Mustafa Kuwait | 40 | 3.6k 1.2× | 2.5k 0.8× | 686 0.4× | 1.4k 1.6× | 1.5k 4.3× | 184 | 5.0k | ||
| Diana L. Williams United States | 34 | 2.9k 1.0× | 2.4k 0.8× | 1.3k 0.8× | 475 0.5× | 270 0.8× | 73 | 3.5k |
Countries citing papers authored by J van Embden
Since
Specialization
Citations
This map shows the geographic impact of J van Embden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J van Embden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J van Embden more than expected).
Fields of papers citing papers by J van Embden
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by J van Embden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J van Embden. The network helps show where J van Embden may publish in the future.
Co-authorship network of co-authors of J van Embden
This figure shows the co-authorship network connecting the top 25 collaborators of J van Embden. A scholar is included among the top collaborators of J van Embden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J van Embden. J van Embden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Cabello, Felipe C., Stanley N. Cohen, R Curtiss, et al.. (2018). Farewell Stan Stanley Falkow: 1934–2018. Environmental Microbiology. 20(7). 2322–2333.
2.
Leavis, Helen L., Janetta Top, Nathan Shankar, et al.. (2004). A Novel Putative Enterococcal Pathogenicity Island Linked to theespVirulence Gene ofEnterococcus faeciumand Associated with Epidemicity. Journal of Bacteriology. 186(3). 672–682.
3.
Long, Richard, et al.. (1999). Transcontinental Spread of Multidrug-resistant Mycobacterium bovis. American Journal of Respiratory and Critical Care Medicine. 159(6). 2014–2017.
4.
Cousins, Debby, E. Liébana, Alicia Aranaz, et al.. (1998). Evaluation of Four DNA Typing Techniques in Epidemiological Investigations of Bovine Tuberculosis. Journal of Clinical Microbiology. 36(1). 168–178.
5.
Blázquez, Jesús, Sofía Samper, Carlos Martı́n, et al.. (1998). Genetic Characterization of Multidrug-Resistant Mycobacterium bovis Strains from a Hospital Outbreak Involving Human Immunodeficiency Virus-Positive Patients. Journal of Clinical Microbiology. 36(8). 2398–2398.
6.
Samper, Sofía, Carlos Martı́n, Antonio Rivero, et al.. (1997). Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis. AIDS. 11(10). 1237–1242.
7.
Zee, Anneke van der, Frits R. Mooi, J van Embden, & James M. Musser. (1997). Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. Journal of Bacteriology. 179(21). 6609–6617.
8.
Torrea, Gabriela, et al.. (1997). Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis. Journal of Clinical Microbiology. 35(9). 2210–2214.
9.
Blázquez, Jesús, Sofía Samper, Carlos Martı́n, et al.. (1997). Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. Journal of Clinical Microbiology. 35(6). 1390–1393.
10.
Zee, Anneke van der, et al.. (1996). Dynamics of the population structure of Bordetella pertussis as measured by IS 1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology. 142(12). 3479–3485.
11.
Giudice, Giuseppe Del, Alain Gervaix, Paul Costantino, et al.. (1993). Priming to heat shock proteins in infants vaccinated against pertussis. The Journal of Immunology. 150(5). 2025–2032.
12.
Perraut, Ronald, Alexander R. Lussow, Olivier Garraud, et al.. (1993). Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants. Clinical & Experimental Immunology. 93(3). 382–386.
13.
Barrios, Christy S., Alexander R. Lussow, J van Embden, et al.. (1992). Mycobacterial heat‐shock proteins as carrier molecules. II: The use of the 70‐kDa mycobacterial heat‐shock protein as carrier for conjugated vaccinescan circumvent the need for adjuvants and Bacillus Calmette Guérin priming). European Journal of Immunology. 22(6). 1365–1372.
14.
Lussow, Alexander R., Christy S. Barrios, J van Embden, et al.. (1991). Mycobacterial heat‐shock proteins as carrier molecules. European Journal of Immunology. 21(10). 2297–2302.
15.
Söderström, Kalle, Eva Halapi, E Nilsson, et al.. (1990). Synovial Cells Responding to a 65‐kDa Mycobacterial Heat Shock Protein have a High Proportion of a TcRγδ Subtype Uncommon in Peripheral Blood. Scandinavian Journal of Immunology. 32(5). 503–515.
16.
Schooten, Wim C. A. van, et al.. (1989). Dr3-restricted t cells from different hla-dr3-positive individuals recognize the same peptide (amino acids 2–12) of the mycobacterial 65-kda heat-shock protein. European Journal of Immunology. 19(11). 2075–2079.
17.
Bahr, G M, et al.. (1988). Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis.. PubMed. 74(2). 211–5.
18.
Shinnick, Thomas M., D Sweetser, Jelle Thole, J van Embden, & R A Young. (1987). The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG. Infection and Immunity. 55(8). 1932–1935.
19.
Emmrich, Frank, Jelle Thole, J van Embden, & Stefan H. E. Kaufmann. (1986). A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens.. The Journal of Experimental Medicine. 163(4). 1024–1029.
20.
Embden, J van & Stanley N. Cohen. (1973). Molecular and Genetic Studies of an R Factor System Consisting of Independent Transfer and Drug Resistance Plasmids. Journal of Bacteriology. 116(2). 699–709.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Angel Cataldi Breakdown of academic impact, for papers by Sofía Samper Breakdown of academic impact, for papers by Desmond M. Collins Breakdown of academic impact, for papers by Sjoukje Kuijper Breakdown of academic impact, for papers by J D van Embden Breakdown of academic impact, for papers by Geoffrey W. de Lisle Breakdown of academic impact, for papers by Janet Fyfe Breakdown of academic impact, for papers by Iñaki Comas Breakdown of academic impact, for papers by Abu Salim Mustafa Breakdown of academic impact, for papers by Diana L. Williams